Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Acumen Pharmaceuticals, Inc. - Common Stock
(NQ:
ABOS
)
2.810
+0.090 (+3.31%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Acumen Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
Next >
These stocks have an unusual volume in today's session
↗
January 28, 2026
Via
Chartmill
Tuesday's after hours session: top gainers and losers
↗
January 27, 2026
Via
Chartmill
The market is filled with gapping stocks in Monday's session.
↗
January 26, 2026
Via
Chartmill
Acumen Pharmaceuticals Inc (NASDAQ:ABOS) Reports Q3 2025 Earnings, Beats EPS Estimates
↗
November 12, 2025
Acumen Pharmaceuticals posts better-than-expected Q3 2025 results, advancing its Alzheimer's treatment pipeline with cash into 2027.
Via
Chartmill
Topics
Earnings
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
Acumen Pharmaceuticals's Earnings: A Preview
↗
August 11, 2025
Via
Benzinga
A Preview Of Acumen Pharmaceuticals's Earnings
↗
May 12, 2025
Via
Benzinga
Preview: Acumen Pharmaceuticals's Earnings
↗
March 26, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Preview: Acumen Pharmaceuticals's Earnings
↗
November 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 25, 2025
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.
Via
Benzinga
Tesla To $345? Here Are 10 Top Analyst Forecasts For Friday
↗
March 28, 2025
Via
Benzinga
Acumen Pharmaceuticals Earnings Preview
↗
November 11, 2024
Via
Benzinga
ABOS Stock Earnings: Acumen Pharmaceuticals Misses EPS for Q2 2024
↗
August 13, 2024
ABOS stock results show that Acumen Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Acumen Pharmaceuticals's Earnings: A Preview
↗
March 25, 2024
Via
Benzinga
Acumen Pharmaceuticals's Earnings Outlook
↗
November 10, 2023
Via
Benzinga
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
Earnings Scheduled For March 27, 2025
↗
March 27, 2025
Via
Benzinga
Trading SMID Biotech Stocks In A Volatile Market
↗
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
ABOS Stock Earnings: Acumen Pharmaceuticals Beats EPS for Q1 2024
↗
May 14, 2024
ABOS stock results show that Acumen Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 14, 2024
Via
Benzinga
ABOS Stock Earnings: Acumen Pharmaceuticals Misses EPS for Q4 2023
↗
March 26, 2024
ABOS stock results show that Acumen Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot
↗
January 30, 2024
Healthcare stocks to buy are not talked about as much right now, but are great stocks investors should consider adding.
Via
InvestorPlace
3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom
↗
January 24, 2024
These three aging stocks offer different thematic approaches to profit from the opportunities that exist in an aging population.
Via
InvestorPlace
Earnings Scheduled For March 26, 2024
↗
March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
Via
Benzinga
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
↗
November 20, 2023
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.
Via
Talk Markets
Topics
ETFs
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
↗
November 17, 2023
Biotech companies are edging closer to finding the answers behind Alzheimer's disease.
Via
Investor's Business Daily
Earnings Scheduled For November 13, 2023
↗
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
↗
November 09, 2023
Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.
Via
InvestorPlace
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
